Navigation Links
Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line
Date:10/29/2009

BOSTON, Oct. 29 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received purchase orders for its MammoView(TM) line of surgical endoscopy instruments from University of California, San Diego Medical Center, San Diego California. UCSD Medical Center is highly regarded in the industry as it provides a significant amount of healthcare in San Diego. UCSD Medical Center operates a network of outpatient practices, free clinics and community-based services.

UCSD Medical Center was named among the best in the nation in six specialty areas, in addition to possessing eighty physicians who earned a place in San Diego Magazine's 2009 "Physicians of Exceptional Excellence." UCSD Medical Center is home to one of just 39 National Cancer Institute-designated Comprehensive Cancer Centers in the United States. Such centers are prominent among the leading institutions in the nation dedicated to scientific innovation and clinical excellence. UCSD is the only Comprehensive Cancer Center in San Diego and Imperial counties to have earned this honor.

"We are extremely pleased to be a supplier to such a distinguished medical institution that is one of the top health care providers in the United States. We believe that our MammoView line will be instrumental in serving UCSD Medical Center wellness initiatives," stated Bob Segersten, President of Solos Endoscopy, Inc.

Solos Endoscopy recently announced that the Company has taken the initial steps to get the CE Marking for its FDA approved MammoView(TM) line of surgical instruments. This will allow the MammoView(TM) line to be sold throughout the European Economic Union (EEU), which represents 30% or $94 Billion of the worldwide demand for medical instruments.

For more information on UCSD Medical Center, please visit: www.ucsd.edu

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a HealthCare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office with its catalog of FDA Approved products. Additional information is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

SOURCE Solos Endoscopy, Inc.


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy, Inc. Receives Additional Purchase Orders from National Cancer Institute and National Institute of Health for its MammoView(TM) Product Line
2. Solos Endoscopy, Inc. Receives Multiple Purchase Orders for its MammoView(TM) Product Line
3. Solos Endoscopy, Inc.s FDA Approved MammoView(TM) Product Line to Obtain CE Mark
4. Solos Endoscopy, Inc.s MammoView(TM) Product Line to be Demonstrated at the 95th Annual American College of Surgeons Clinical Congress
5. New Study Confirms Dose-Accuracy of SoloSTAR(R) Prefilled Insulin Pen
6. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
7. Asthmatx Receives FDA Advisory Panel Recommendation for Approvable with Conditions for Bronchial Thermoplasty with the Alair(R) System for Severe Asthma
8. CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R)
9. Lumenis Receives 510K Clearance for the PolyScope Disposable Flexible Endoscope
10. Dr. Mark Popovsky Receives Prominent Award for Leadership in Transfusion Medicine
11. Pharmalink AB Receives Patent for Nefecon(R) Principle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017 Regulus Therapeutics ... discovery and development of innovative medicines targeting microRNAs, today ... 2016 financial results on Thursday, March 2, 2017 after ... conference call and webcast on March 2, 2017 at ... full year 2016 financial results and provide a general ...
(Date:2/23/2017)... The fast-growing cannabis market is expected to create ... According to the 2017 Legal Marijuana Outlook, published by New ... jobs by 2020, with an implied growth rate of more ... accelerating pace of cannabis legalization is considered as the main ... will further create more business ventures and boost the economy. ...
(Date:2/23/2017)... South Korea , Feb. 23, 2017 LG Innotek ... UV-C LED for sterilization applications. As its sterilization performance is 1.5 ... produces the short wavelength ultraviolet rays in the range of 200 -- ... the proliferation of bacteria by destroying their DNA. LG Innotek,s product ... ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... February 23, 2017 , ... Top cosmetic and periodontal ... program today with a new Indiegogo campaign . Individuals are now able ... in the Los Angeles area, either as a participating patient or through an Indiegogo ...
(Date:2/23/2017)... ... 2017 , ... Thomas Vas-Don suffered from severe injury due to ... able to successfully recover. In “ Origin & Insertion Charts for Massage Therapists ” ... principals of massage, anatomy , trigger points and referral pain patterns . ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... It’s enough to overwork even the sharpest brain. , Power On, a mental ... activity without over clocking the brain. Each capsule contains Cognizin® Citicoline, a branded ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... The ... to the thousands of individuals who have recently fallen victim to America’s opioid epidemic. ... in Orange County, California, where they are free from the shame, stigma, and ...
(Date:2/22/2017)... Northbrook, IL (PRWEB) , ... February 22, 2017 , ... ... stories, is proud to once again feature Heroes On The Water (HOW), a non-profit ... This season’s all new episode has series host ‘Mike D’ traveling to Lake Denmark, ...
Breaking Medicine News(10 mins):